National Heart Lung & Blood Institute
This article was originally published in The Gray Sheet
Phase I grant to Implant Sciences covers development of a "radioactive coronary stent with multiple half lives." The device will utilize two radioactive isotopes "providing longer range radioisotopes at each end that will provide a higher dose of radiation beyond the ends of the stent" to help prevent restenosis, the Wakefield, Massachusetts firm says
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.